Recently Featured

A Year of Scrutiny for Health Insurers

December 10, 2025
In the past year, health insurers have faced unprecedented scrutiny, culminating in regulatory pressures and public outcry over their practices. This heightened examination follows a series of controversial actions by major players in the industry, including UnitedHealthcare, which recently experienced a tragic incident involving its CEO. The fallout from such events has not only amplified…

ACIP Delays Vote on Hepatitis B Birth Dose to Friday

December 10, 2025
The CDC’s Advisory Committee on Immunization Practices (ACIP) has postponed its vote regarding the timing of the hepatitis B vaccine for newborns, moving the decision to Friday. This marks the second delay in recent weeks, reflecting ongoing confusion and frustration surrounding the committee’s discussions and the language used in the proposed guidelines. This postponement comes…

Vinay Prasad Defends FDA Vaccine Policy Amid Rising Criticism

December 10, 2025
NEW YORK — Vinay Prasad, the Food and Drug Administration’s top vaccines regulator, attributed the mounting criticism of his leadership to what he described as “misleading media narratives.” His comments, made during a closed-door investor conference in New York, come in the wake of a public warning issued by 12 former FDA commissioners regarding his…

CDC Panel Again Postpones Vote on Newborns’ Hepatitis B Shot

December 10, 2025
A high-stakes meeting with wide-ranging public health implications again didn’t result in a vote, as members struggled to agree on the recommendations they’ll weigh in on. The postponement of the vote by the CDC panel regarding the hepatitis B vaccination for newborns raises significant concerns within the pharmaceutical and healthcare sectors, particularly among regulatory and…

Ongoing Cases